Address And Details

PO Box 55932 , Boston, MA 02205-5932
Fund Manager Andrew Acker
Manager Tenure 12 Years 2 Months

Strategy And Objective

Janus Henderson Global Life Sciences Fund seeks long-term growth of capital. The Fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio manager believes have a life science orientation. In the Fund s pursuit of companies with a life science orientation, the Fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the life sciences sector, which may include companies in the following industry groups: pharmaceutical; biotechnology; health care services; and medical devices. Generally speaking, the life sciences relate to maintaining or improving quality of life. So, for example, companies with a life science orientation include companies engaged in research, development, production, or distribution of products or services related to health and personal care, medicine, or pharmaceuticals. The Fund implements its investment policies by investing primarily in equity securities of U.S. and foreign companies selected for their growth potential. The Fund normally invests in issuers from several different countries, which may include the United States. The Fund may, under unusual circumstances, invest in a single country. The Fund may have exposure to emerging markets. The Fund may invest in shares of companies through initial public offerings. The portfolio manager applies a bottom up approach in choosing investments. In other words, the portfolio manager looks at companies one at a time to determine if a company is an attractive investment opportunity and if it is consistent with the Fund s investment policies. The Fund may lend portfolio securities on a short-term or long-term basis, in an amount equal to up to one-third of its total assets as determined at the time of the loan origination.

Net Asset Value

as of 6:00 PM ET 09/27/2021

Performance

  • 1 Week
  • +0.39%
  • 1 Month
  • -1.57%
  • 3 Months
  • +0.64%
  • 1 Yr Return
  • +12.62%
  • 5 Yr Return
  • +46.08%

Equity Sector Breakdown

Health 61.56%
Finance 10.49%
Services 9.82%
Technology 5.59%
IndustrialCyclical 5.52%
ConsumerDurables n/a
Energy n/a
NonDurables n/a
RetailTrade n/a
Utilities n/a

Asset Allocation

Asset Type % Of Allocation
Stocks 97.42%
ForeignStocks 19.93%
Preferred 2.06%
Cash 0.00%
Bonds 0.00%
Convertible 0.00%
Other 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 28.94 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha 0.43 0.43 4.43
Beta 0.80 0.83 0.87
R Squared 0.73 0.65 0.55
Std Deviation 17.36 15.50 15.68
Sharpe Ratio 0.88 0.99 n/a

Purchase Information

as of 5:34 PM ET 09/24/2021
Minimum Initial $2500
Minimum Additional $0
Minimum Initial IRA $500

Performance

Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +21.62%
  • +24.74%
+21.62% +24.74%
3 Year
  • +14.81%
  • +16.92%
+14.81% +16.92%
10 Year
  • +18.60%
  • +17.27%
+18.60% +17.27%
Life Of Fund
  • +18.02%
  • +17.97%
+18.02% +17.97%

Top 10 Holdings

Symbol Company Name % Of Assets
AZN:LN ASTRAZENECA PLC 4.49%
UNH UNITEDHEALTH GROUP INC 3.97%
ROG ROCHE HOLDING AG 2.91%
ABBV ABBVIE INC 2.80%
MRK MERCK & CO 2.75%
NVS NOVARTIS AG ADR 2.58%
HUM HUMANA INC 2.46%
BSX BOSTON SCIENTIFIC CORP 2.45%
ABT ABBOTT LABORATORIES 2.29%
TMO THERMO FISHER SCIENTIFIC INC 2.28%

Recent Articles from TheStreet

3. Micron Technology Inc. (MU)

Micron Technology Drops on Weak Outlook for First Quarter

Micron topped analysts' fourth quarter expectations but provided tepid outlook for the first quarter.

Ford Lead

Stock Market Today With Jim Cramer: Buy Ford

Jim Cramer discusses how to trade tech stocks during a selloff and Ford's EV plans.

NYSE Stock Market Wall Street Bull

Jim Cramer's Tale of Two Market Bulls

Fed's Powell and China's Xi have different goals but similar effects on markets.

Chewy Pet Food Lead

Chewy Lifted to Outperform; Wolfe Sees 'Strong Growth Ahead'

Wolfe Research upgraded Chewy to outperform, saying a drop in net new customer additions should reverse in fiscal 2022.

Meditating on the Toilet and 7 Other Ways to Relax at Work

The Questions Investors Should be Asking Themselves

Ahead of third-quarter earnings season, James 'Rev Shark' Deporre has some thoughts on what investors should be thinking about.

iPhone Apple Lead

Will a Market Correction Make Apple Stock a Buy?

Apple stock is trying to hold up, but is struggling amid the market correction. Here's where support may come into play.

Gogo Inflight Internet Lead

5 Top Stock Gainers for Tuesday: Gogo, Huntsman, Thor Industries

Gogo, Huntsman, Thor Industries, United Natural Foods and Sonoma Pharmaceuticals are five top stock gainers for Tuesday.

Wall Street Preview: Investors Turn to Tech

Dow Ends Down Over 500 Points, Nasdaq Has Worst Close Since March

Stocks end sharply lower Tuesday as Wall Street contends with rolling blackouts in China, record high energy prices in Europe and gas line-ups in Britain.

Aurora Cannabis Raises $345 Million Through Debt Offering

Aurora Cannabis Stock Rises; Cowen Affirms Market Perform

Aurora Cannabis had a tough quarter, but Cowen analysts still expect strong growth margins in 2022.

The New Ford Maverick

How Far Can Ford Stock Rally Right Now?

Ford stock still trades well on the long side. It may be time to book some profit and raise our stop-loss on this great trade, while looking for more upside.